Analysis of the gut microbiome of rural and urban healthy indians living in sea level and high altitude areas by Das, B, Ghosh, T, Kedia, S, Rampal, R, Saxena, S, Bag, S, Mitra, R, Dayal, M, Mehta, O, Surendranath, A, Travis, S, Tripathi, P, Nair, G, Ahuja, V

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies by Mughal, TI, Pemmaraju, N, Psaila, B, Radich, J, Bose, P, Lion, T, Kiladjian, J-J, Rampal, R, Jain, T, Verstovsek, S, Yacoub, A, Cortes, JE, Mesa, R, Saglio, G, van Etten, RA

Ruxolitinib therapy followed by reduced-intensity conditioning for hematopoietic cell transplantation for myelofibrosis: Myeloproliferative Disorders Research Consortium 114 study by Gupta, V, Kosiorek, H, Mead, A, Klisovic, R, Galvin, J, Berenzon, D, Yacoub, A, Viswabandya, A, Mesa, R, Goldberg, J, Price, L, Salama, M, Weinberg, R, Rampal, R, Farnoud, N, Dueck, A, Mascarenhas, J, Hoffman, R